IMP9064

· Impact Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMP9064, covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing